Sort
15,842 grants matching “pancreatic cancer”
Core 2: Animal Model and Experimental Therapeutics Core [AMETC]
$253,150Maneesh Jain · University Of Nebraska Medical Center · P01 · FY2021 · CA
Core 1: Administrative and Bioinformatics Core
$253,150Surinder Kumar Batra · University Of Nebraska Medical Center · P01 · FY2021 · CA
Core 2: Animal Model and Experimental Therapeutics Core [AMETC]
$253,150Maneesh Jain · University Of Nebraska Medical Center · P01 · FY2020 · CA
Core 1: Administrative and Bioinformatics Core
$253,012Surinder Kumar Batra · University Of Nebraska Medical Center · P01 · FY2018 · CA
Core 2: Animal Model and Experimental Therapeutics Core [AMETC]
$253,011Maneesh Jain · University Of Nebraska Medical Center · P01 · FY2018 · CA
Role of Mineralocorticoids in Hypertension
$253,000Celso Enrique Gomez-Sanchez · University Of Mississippi Med Ctr · R01 · FY2011 · HL
Role of Mineralocorticoids in Hypertension
$253,000Celso Enrique Gomez-Sanchez · University Of Mississippi Med Ctr · R01 · FY2010 · HL
Microenvironmental Transport for Immunotherapy in Pancreatic Cancer
$252,940Jason B Fleming · Methodist Hospital Research Institute · U54 · FY2016 · CA
Tea Modulation of Colon Carcinogenesis
$252,904Michael Wargovich · University Of South Carolina At Columbia · R01 · FY2006 · CA
Kinase Imaging
$252,886Lee Josephson · Massachusetts General Hospital · P50 · FY2009 · CA
Theory of Protein-Protein Association
$252,835Huan-Xiang Zhou · Florida State University · R01 · FY2010 · GM
Experimental Therapeutics
$252,828Israel David Goldman · Albert Einstein College Of Medicine · P30 · FY2015 · CA
Experimental Therapeutics
$252,828Israel David Goldman · Albert Einstein College Of Medicine, Inc · P30 · FY2015 · CA
Regulation of medulloblastoma tumor growth by SPARC
$252,801Sajani Lakka · University Of Illinois At Chicago · R01 · FY2012 · CA
Regulation of medulloblastoma tumor growth by SPARC
$252,801Sajani Lakka · University Of Illinois At Chicago · R01 · FY2011 · CA
EFFICACY OF ANTIOXIDANT USE IN PANCREATIC CANCER
$252,714Jeanne A Drisko · University Of Kansas Medical Center · M01 · FY2007 · RR
IAPs As Novel Targets for Cancer Therapy
$252,700Emory University · R01 · FY2005 · CA
Cost Effectiveness of Germline Genetic Testing in Pancreatic Cancer
$252,664Mary Linton B Peters · Beth Israel Deaconess Medical Center · K08 · FY2022 · CA
Cost Effectiveness of Germline Genetic Testing in Pancreatic Cancer
$252,664Mary Linton B Peters · Beth Israel Deaconess Medical Center · K08 · FY2021 · CA
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
$252,589Farrokh Dehdashti · Washington University · R01 · FY2024 · CA
METABOLIC ENGINEERING OF REACTIVE GLYCOCONJUGATES
$252,499University Of California Berkeley · R01 · FY2001 · GM
The Antigen Targeting Core
$252,483Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
Metabolic adaptations to crisantaspase treatment mediated by the pancreatic ductal adenocarcinoma
$252,230Dominique Bollino · West Virginia University · P20 · FY2025 · GM
Targeting Stroma to Improve Therapy of Pancreatic Adenocarcinoma
$252,219Yves Boucher · Massachusetts General Hospital · P01 · FY2012 · CA
Cost Effectiveness of Germline Genetic Testing in Pancreatic Cancer
$252,164Mary Linton B Peters · Beth Israel Deaconess Medical Center · K08 · FY2023 · CA